Literature DB >> 24156740

Sulfonamides incorporating fluorine and 1,3,5-triazine moieties are effective inhibitors of three β-class carbonic anhydrases from Mycobacterium tuberculosis.

Mariangela Ceruso1, Daniela Vullo, Andrea Scozzafava, Claudiu T Supuran.   

Abstract

A new series of fluorine containing 1,3,5-triazinyl sulfonamide derivatives obtained from cyanuric fluoride, sulfanilamide/4-aminoethylbenzenesulfonamide followed and incorporating also amin0, amino alcohol and amino acid moieties have been investigated as inhibitors of three β-carbonic anhydrases (CAs, EC 4.2.1.1) from the bacterial pathogen Mycobacterium tuberculosis, mtCA1 (Rv1284), mtCA 2 (Rv3588c) and mtCA 3 (Rv3273). All three enzymes were efficiently inhibited by these sulfonamides with KI values in the nanomolar or submicromolar range, depending on the substitution of one or both fluorine atoms at the 1,3,5-triazine ring. As some of these enzymes are crucial for the life cycle of this bacterium, the class of β-CA inhibitors reported in this study may lead to antimycobacterial agents with a different mechanism of action compared to the clinically used such drugs for which the pathogen developed extensive drug resistance.

Entities:  

Keywords:  1,3,5-triazine; Mycobacterium tuberculosis; carbonic anhydrase; fluoride; sulfonamide; β-Carbonic anhydrases

Mesh:

Substances:

Year:  2013        PMID: 24156740     DOI: 10.3109/14756366.2013.842233

Source DB:  PubMed          Journal:  J Enzyme Inhib Med Chem        ISSN: 1475-6366            Impact factor:   5.051


  14 in total

Review 1.  Small Molecules That Sabotage Bacterial Virulence.

Authors:  Benjamin K Johnson; Robert B Abramovitch
Journal:  Trends Pharmacol Sci       Date:  2017-02-14       Impact factor: 14.819

2.  Sulfanilamide Modified Magnetic Nanoparticles for Purification of Carbonic Anhydrase from Bovine Blood.

Authors:  Safinur Yıldırım Çelik; Kübra Solak; Ahmet Mavi
Journal:  Appl Biochem Biotechnol       Date:  2022-06-01       Impact factor: 2.926

Review 3.  An Overview of the Bacterial Carbonic Anhydrases.

Authors:  Claudiu T Supuran; Clemente Capasso
Journal:  Metabolites       Date:  2017-11-11

4.  Novel Sulfamethoxazole Ureas and Oxalamide as Potential Antimycobacterial Agents.

Authors:  Martin Krátký; Jiřina Stolaříková; Jarmila Vinšová
Journal:  Molecules       Date:  2017-03-28       Impact factor: 4.411

5.  Comparison of the Sulfonamide Inhibition Profiles of the β- and γ-Carbonic Anhydrases from the Pathogenic Bacterium Burkholderia pseudomallei.

Authors:  Daniela Vullo; Sonia Del Prete; Pietro Di Fonzo; Vincenzo Carginale; W Alexander Donald; Claudiu T Supuran; Clemente Capasso
Journal:  Molecules       Date:  2017-03-07       Impact factor: 4.411

Review 6.  Carbonic Anhydrase Inhibitors as Novel Drugs against Mycobacterial β-Carbonic Anhydrases: An Update on In Vitro and In Vivo Studies.

Authors:  Ashok Aspatwar; Jean-Yves Winum; Fabrizio Carta; Claudiu T Supuran; Milka Hammaren; Mataleena Parikka; Seppo Parkkila
Journal:  Molecules       Date:  2018-11-08       Impact factor: 4.411

7.  Bacterial ι-carbonic anhydrase: a new active class of carbonic anhydrase identified in the genome of the Gram-negative bacterium Burkholderia territorii.

Authors:  Sonia Del Prete; Alessio Nocentini; Claudiu T Supuran; Clemente Capasso
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

8.  Anion Inhibition Studies of the Beta-Carbonic Anhydrase from Escherichia coli.

Authors:  Sonia Del Prete; Viviana De Luca; Alessio Nocentini; Andrea Scaloni; Margaret D Mastrolorenzo; Claudiu T Supuran; Clemente Capasso
Journal:  Molecules       Date:  2020-05-31       Impact factor: 4.411

9.  The Effect of Substituted Benzene-Sulfonamides and Clinically Licensed Drugs on the Catalytic Activity of CynT2, a Carbonic Anhydrase Crucial for Escherichia coli Life Cycle.

Authors:  Sonia Del Prete; Viviana De Luca; Silvia Bua; Alessio Nocentini; Vincenzo Carginale; Claudiu T Supuran; Clemente Capasso
Journal:  Int J Mol Sci       Date:  2020-06-11       Impact factor: 5.923

Review 10.  Mycobacterium tuberculosis β-Carbonic Anhydrases: Novel Targets for Developing Antituberculosis Drugs.

Authors:  Ashok Aspatwar; Visvaldas Kairys; Sangeetha Rala; Mataleena Parikka; Murat Bozdag; Fabrizio Carta; Claudiu T Supuran; Seppo Parkkila
Journal:  Int J Mol Sci       Date:  2019-10-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.